FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.5  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym Active Entire term case insensitive SNOMED CT core module
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442103019 2 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    2 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely nitrofural 2 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely esterified estrogen 625 microgram and methyltestosterone 1.25 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 chewing gum prolonged-release oral gum (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely paracetamol 24 milligram/1 milliliter and promethazine hydrochloride 300 microgram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely mucin 63 milligram and xylitol 39 milligram/1 each conventional release oromucosal lozenge (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely theophylline 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely ipratropium bromide 167 microgram/1 milliliter and salbutamol (as salbutamol sulfate) 833 microgram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely bupivacaine hydrochloride 2.5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely Frangula 80 microgram/1 milligram and Sterculia gum 620 microgram/1 milligram conventional release oral granules (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely piperacillin (as piperacillin sodium) 3 gram and tazobactam (as tazobactam sodium) 375 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cefepime (as cefepime hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely calcium carbonate 1.5 gram and colecalciferol 10 microgram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ampicillin (as ampicillin sodium) 1 gram and sulbactam (as sulbactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely estrone 2 milligram/1 milliliter conventional release suspension for injection (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely nafcillin (as nafcillin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely ampicillin (as ampicillin sodium) 2 gram and sulbactam (as sulbactam sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely alprazolam 2 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely oxacillin (as oxacillin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely cefotetan (as cefotetan disodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely amoxicillin 125 milligram and clavulanic acid (as clavulanate potassium) 31.2 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely calcium electrolyte 1.25 gram and colecalciferol 10 microgram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely omeprazole 40 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely diazepam 2 milligram/1 milliliter conventional release rectal solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely omeprazole 20 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely sodium benzoate 100 milligram/1 milliliter and sodium phenylacetate 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely porcine isophane insulin 70 unit/1 milliliter and porcine regular insulin 30 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely human isophane insulin 90 unit/1 milliliter and recombinant human regular insulin 10 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dextromethorphan hydrobromide 3 milligram/1 milliliter and promethazine hydrochloride 1.25 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely caffeine 650 microgram/1 milliliter and paracetamol 5 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dexamethasone 1 milligram/1 milliliter and hypromellose 5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely bromazine hydrochloride 2.5 milligram/1 milliliter and codeine phosphate 2 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely naphazoline hydrochloride 270 microgram/1 milliliter and pheniramine maleate 3.15 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and codeine phosphate 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely citalopram (as citalopram hydrobromide) 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely ibuprofen 20 milligram/1 milliliter and pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol 1.88 microgram/1 hour and levonorgestrel 625 nanogram/1 hour prolonged-release transdermal patch (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely methylprednisolone 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 1 milligram/1 milliliter and kaolin 300 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fenoterol 500 microgram and ipratropium 1.25 milligram/1 actuation conventional release solution for inhalation (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely diprophylline 6.67 milligram/1 milliliter and guaifenesin 6.67 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely bupivacaine hydrochloride 7.5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely calcium carbonate 6.25 milligram/1 milliliter and colecalciferol 2.2 unit/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely diphenhydramine hydrochloride 20 milligram/1 milliliter and zinc acetate 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter and sodium nitrite 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely thioridazine 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely codeine phosphate 2 milligram/1 milliliter and promethazine hydrochloride 1.25 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fluorescein sodium stain 2.5 milligram/1 milliliter and proxymetacaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cocaine (as cocaine hydrochloride) 20 milligram/1 milliliter and homatropine hydrobromide 20 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 2
    Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release ear solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely memantine hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely miconazole nitrate 2.5 milligram/1 gram and zinc oxide 150 milligram/1 gram conventional release cutaneous ointment (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lidocaine hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely clonazepam 2 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely choline 200 milligram/1 milliliter and glycerol 126 milligram/1 milliliter conventional release ear solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely gemcitabine (as gemcitabine hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely glucose 40 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely glucose 50 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely epinephrine 10 microgram/1 milliliter and lidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 21.7 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely epinephrine (as epinephrine bitartrate) 500 microgram/1 milliliter and guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 333 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely epinephrine (as epinephrine bitartrate) 1 milligram/1 milliliter and guanethidine 5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier

    Start Previous Page 21 of 35 Next End

    This concept is not in any reference sets

    Back to Start